Skip to main content

Table 2 Means ± s.e. for each variable calculated in the two groups of patients at baseline, and at 3, 6, and 12 months of treatments (n = 40 + 40 matched)

From: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma

  Group A
(means ± s.e.)
Group B
(means ± s.e.)
  T0 T3 T6 T12 T0 T3 T6 T12
FEV1% pred. 82.40
± 1.69
87.08
± 1.58
89.98
± 2.0
91.88
± 2.13
81.93
± 2.0
89.50
± 2.64
90.9
± 3.23
99.1
± 3.24
Exac. Rate/p 0.63
± 0.13
0.53
± 0.12
0.58
± 0.13
0.60
± 0.18
1.05
± 0.16
0.28
± 0.07
0.33
± 0.08
0.18
± 0.08
Hosp. rate/p. 0.25
± 0.07
0.15
±0.06
0.08
± 0.04
0.13
± 0.05
0.30
± 0.07
0.08
± 0.04
0.10
± 0.05
0.03
± 0.03
H. duration (days) 0.83
± 0.26
0.28
± 0.12
0.48
± 0.38
0.60
± 0.31
0.88
± 0.31
0.08
± 0.04
0.10
± 0.05
0.03
± 0.03
Inactivity
(days)/p
2.88
± 0.63
1.53
± 0.27
1.10
± 0.21
1.45
± 0.58
3.35
± 0.63
0.60
± 0.19
1.35
± 0.34
0.83
± 0.39
Spec. Visits/p 0.68
± 0.13
0.68
± 0.11
0.65
± 0.08
1.05
± 0.13
0.70
± 0.16
0.28
± 0.07
0.35
± 0.08
0.23
± 0.08
GP visits/p 1.33
± 0.23
0.85
± 0.15
0.55
± 0.13
0.63
± 0.15
1.53
± 0.24
0.38
± 0.12
0.78
± 0.12
0.25
± 0.09
Courses of steroids/p 0.90
± 0.15
0.73
0.13
0.48
± 0.11
0.30
± 0.09
1.08
± 0.16
0.33
0.08
0.30
± 0.08
0.13
± 0.06
Courses of antibiotics/p. 0.85
± 0.16
0.63
0.10
0.43
± 0.12
0.40
± 0.11
1.03
± 0.13
0.35
0.08
0.33
± 0.08
0.15
± 0.08
  1. Group A: Beclomethasone dipropionate/Formoterol (BDP/F) 100/6 μg b.i.d., via Nexthaler. Group B: Fluticasone furoate/Vilanterol (FF/V) 92/22 μg o.d., via Ellipta